The study, conducted by researchers with the Centers for Disease Control and Prevention (CDC), found that six bacterial ...

The agent MRX-I, an oral oxazolidinone antibiotic, targets infections due to multi-drug resistant Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and ...

Exposure to the antibiotics did not increase the risk for vancomycin-resistant Enterococcus colonization. Few patients tested positive for VRE overall, so the authors said more research is needed.

MRSA was once eradicated reliably by vancomycin (Vancocin AE), an antibiotic of the glycopeptide class. With time, the MRSA bacteria became resistant to vancomycin and vancomycin-resistant ...

Increased VISA growth in diabetic infection Vancomycin is frequently used to treat MRSA-associated bacteremia. Infection with vancomycin intermediate-resistance S. aureus (VISA) strains are three ...

While the prevalence of VISA and VRSA remains low, concerns about vancomycin resistance and the lack of a clinical or bacteriological response with as many as 18% of MRSA isolates with a ...

Department of Chemistry, University of California, Irvine, Irvine, California 92697, United States Department of Pharmaceutical Sciences, University of California, Irvine, Irvine, California 92697, ...

Weifang Key Laboratory of Respiratory Tract Pathogens and Drug Therapy, School of Life Science and Technology, Shandong Second Medical University, Weifang 261000, P. R. China ...

Among the resistant organisms reported, MRSA had the highest pooled prevalence (6.23%; CI: 3.83–9.97%), followed by ESBL (6.19%; CI: 3.32–11.26%), and lastly VRE with the lowest reported prevalence (1 ...

and vancomycin. The short-lived ROS and RNS generated by plasma played a primary role in the process and induced the increase of many species of ROS and RNS in MRSA cells. Thus, our data indicated ...